Pre-admission Hyperglycemia and Its Effect on Morbidity and Mortality
NCT ID: NCT00871832
Last Updated: 2013-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2007-05-31
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hyperglycemia in the Intensive Care Unit, a Prevalence Study
NCT00854347
Impact of 2 Blood Glucose Levels on Hospital Mortality in Patients Admitted in ICU
NCT00591071
The Association Between Peri-Operative Hyperglycemia and Major Morbidity and Mortality
NCT00487162
TPN-Induced Hyperglycemia: Impact on Clinical Outcome in Intensive Care Unit (ICU) and Non-ICU Patients
NCT00604669
Admission Glucose ICU Study
NCT00569322
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Staten Island University Hospital
OTHER
Northwell Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mario Castellanos
Clinical Director of Research, Dept. of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mario Castellanos, MD
Role: PRINCIPAL_INVESTIGATOR
Staten Island University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Staten Island University Hospital
Staten Island, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07-020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.